36 results
6-K
EX-99.1
TAK
Takeda Pharmaceutical Company Limited
19 Apr 24
Current report (foreign)
6:12am
dosing with ENTYVIO and refer to neurologist; if confirmed, discontinue ENTYVIO dosing permanently. Liver Injury: There have been reports … of significant liver injury. Live and Oral Vaccines: Prior to initiating treatment with ENTYVIO, all patients should be brought up to date with all
6-K
TAK
Takeda Pharmaceutical Company Limited
28 Sep 23
Current report (foreign)
6:17am
, withhold dosing with ENTYVIO and refer to neurologist; if confirmed, discontinue ENTYVIO dosing permanently.
Liver Injury: There have been reports … evidence of significant liver injury.
Live and Oral Vaccines: Prior to initiating treatment with ENTYVIO, all patients should be brought up to date with all
6-K
5zdgf3h2w9g 630m02
8 Dec 22
Current report (foreign)
6:46am
6-K
EX-99.1
ajt3jqykkuej2txit5j
23 Aug 22
Current report (foreign)
6:13am
S-8
EX-99.1
qx3sk5am
29 Jun 22
Registration of securities for employees
6:13am
6-K
EX-99.1
gbrw ff61a7g67
6 Apr 21
Current report (foreign)
6:29am
6-K
EX-99.1
sfvyaqe ff28
17 Dec 20
Current report (foreign)
6:01am
6-K
EX-99.1
ttsdz9y06xjjar js6
10 Jan 20
Better Health, Brighter Future 2019 SUSTAINABLE VALUE REPORT Takeda Pharmaceutical Company Limited
6:36am
6-K
EX-99.1
n9oc zt55zanpzqh
21 Nov 19
Current report (foreign)
6:08am
6-K
EX-99.1
olieauwn0gri8e
14 Nov 19
Current report (foreign)
6:26am
424B3
zg6oyiupl
14 Nov 19
Prospectus supplement
6:10am
F-4/A
5mblnj3hzqiqlu63i
12 Nov 19
Registration of securities (foreign) (amended)
9:50am
F-4
uzz17vj0l pxrjao34
9 Aug 19
Registration of securities (foreign)
6:27am
20-F
vtcrvoz
27 Jun 19
Annual report (foreign)
6:41am